There are 2789 resources available
360P - Metronomic temozolomide therapy in heavily pretreated patients with recurrent glioblastoma: A large mono-institutional retrospective study
Presenter: Vittorina Zagonel
Session: ePoster Display
361P - Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
Presenter: Alexandre Beige
Session: ePoster Display
362P - Influence of the expression of ABCG2 transporters on the results of photodynamic therapy in malignant gliomas
Presenter: Artemii Rynda
Session: ePoster Display
363P - Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study
Presenter: Giuseppe Lombardi
Session: ePoster Display
364P - Implementation of a comprehensive streamlined next generation sequencing (NGS) test for glioma including detection of the 1p/19q codeletion
Presenter: Sian Wood
Session: ePoster Display
425P - Cetuximab could be administered once every two weeks instead of once weekly
Presenter: sarah Lobet
Session: ePoster Display
426P - Spotlight on refractory metastatic colorectal cancer (refMCRC): Role of prognostic characteristics in the continuum of care
Presenter: Augusto Valdivia
Session: ePoster Display
427P - Real world data of trifluridine/tipiracil in refractory mCRC: A multicenter experience at four GEODA Spanish hospitals
Presenter: Julia Martinez Perez
Session: ePoster Display
428P - Retrospective cohort study of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer
Presenter: Hong Qiu
Session: ePoster Display
Resources:
Abstract